Summary
A bioRxiv preprint reports that maintaining 10% oxygen throughout human iPSC-cardiomyocyte differentiation favoured atrial rather than ventricular specification. The laboratory finding could help produce atrial cells but raises process-design concerns for manufacturing ventricular cells.
A bioRxiv preprint reports that continuously maintaining 10% oxygen during the laboratory differentiation of human induced pluripotent stem cell-derived cardiomyocytes shifted the cells toward an atrial rather than ventricular identity. The result emerged from single-cell RNA sequencing alongside cell morphology, ploidy and functional analyses.
The finding was unexpected because the study was designed around the possibility that oxygen conditions resembling those inside a developing heart could improve the maturation of ventricular cardiomyocytes. Instead, the authors say the oxygen condition promoted a different heart-cell subtype.
What the oxygen experiment changed
Induced pluripotent stem cells, or iPSCs, are reprogrammed cells that can be directed to form specialised cell types, including cardiomyocytes. Cardiomyocytes from the atria and ventricles perform different roles in the heart: atrial cells are associated with the receiving chambers, while ventricular cells form the main pumping chambers.
Most iPSC-cardiomyocyte differentiation is performed under atmospheric oxygen. The researchers instead used a GMP-compliant Quad Physoxia glovebox platform to maintain a specified oxygen tension continuously throughout the differentiation process. The experimental condition was 10% oxygen, below the roughly 21% oxygen concentration of ordinary air.
The study focused on iPSC-derived ventricular cardiomyocytes because these cells are being investigated as a possible way to replace ventricular muscle lost after myocardial infarction. The authors note that the immature characteristics of such cells can increase the risk of arrhythmias after transplantation, making maturation and subtype control important manufacturing goals.
How the researchers identified the cell subtype
The researchers used single-cell RNA sequencing to examine gene-expression patterns in individual differentiated cells. They integrated those data with datasets from human cardiomyocytes representing different heart chambers, allowing the resulting cells to be compared with atrial and ventricular reference profiles.
They also assessed cell morphology, ploidy and functional properties rather than relying on gene-expression data alone. Taken together, the analyses indicated that sustained 10% oxygen promoted atrial rather than ventricular iPSC-cardiomyocyte specification.
The supplied abstract does not report a sample size or numerical effect estimates. The work is presented as a bioRxiv preprint and its evidence comes from a human cell-differentiation model, not from transplantation or a clinical study.
Why the result matters for cell manufacturing
For processes intended to generate ventricular cardiomyocytes, an oxygen condition that pushes cells toward an atrial identity could make production less predictable. The authors specifically raise concerns about ventricular-cell manufacturing using sphere technology, in which cells are differentiated in three-dimensional clusters.
The same result could be useful when atrial cardiomyocytes are the intended product. The authors describe sustained 10% oxygen as a relatively straightforward way to refine atrial cell specification, with potential relevance to diagnostic studies, cytotoxicity testing and regenerative research.
The study therefore points to oxygen tension as a controllable variable in determining cardiomyocyte subtype. Its translational evidence level remains cell culture: the preprint evaluates the identity and properties of differentiated cells, while clinical use and transplantation outcomes are future applications rather than results measured in this work.